Mainstream Biotech
Shanghai
About Mainstream Biotech
Mainstream Bio is a biotechnology company grounded in research, specializing in the development of innovative peptide therapeutics 2.0.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $13.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: mainlinebiosciences.com
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/mainstream-biotech-36707 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.